AU680617B2 - The use of hyperimmune milk to increase longevity - Google Patents

The use of hyperimmune milk to increase longevity

Info

Publication number
AU680617B2
AU680617B2 AU45259/93A AU4525993A AU680617B2 AU 680617 B2 AU680617 B2 AU 680617B2 AU 45259/93 A AU45259/93 A AU 45259/93A AU 4525993 A AU4525993 A AU 4525993A AU 680617 B2 AU680617 B2 AU 680617B2
Authority
AU
Australia
Prior art keywords
milk
atcc
animal
human
hyperimmune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU45259/93A
Other languages
English (en)
Other versions
AU4525993A (en
Inventor
Lee R. Beck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stolle Milk Biologics Inc
Original Assignee
Stolle Research and Development Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Research and Development Corp filed Critical Stolle Research and Development Corp
Publication of AU4525993A publication Critical patent/AU4525993A/en
Application granted granted Critical
Publication of AU680617B2 publication Critical patent/AU680617B2/en
Assigned to STOLLE MILK BIOLOGICS, INC. reassignment STOLLE MILK BIOLOGICS, INC. Alteration of Name(s) in Register under S187 Assignors: STOLLE RESEARCH & DEVELOPMENT CORPORATION
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AU45259/93A 1992-06-16 1993-05-26 The use of hyperimmune milk to increase longevity Ceased AU680617B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US053649 1979-06-29
US89951992A 1992-06-16 1992-06-16
US899519 1992-06-16
US5364993A 1993-04-28 1993-04-28
PCT/US1993/005199 WO1993025232A1 (en) 1992-06-16 1993-05-26 The use of hyperimmune milk to increase longevity

Publications (2)

Publication Number Publication Date
AU4525993A AU4525993A (en) 1994-01-04
AU680617B2 true AU680617B2 (en) 1997-08-07

Family

ID=26732096

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45259/93A Ceased AU680617B2 (en) 1992-06-16 1993-05-26 The use of hyperimmune milk to increase longevity

Country Status (7)

Country Link
EP (1) EP0646014A4 (ja)
JP (1) JPH07507798A (ja)
AU (1) AU680617B2 (ja)
CA (1) CA2136641A1 (ja)
IL (1) IL105912A (ja)
NZ (3) NZ299579A (ja)
WO (1) WO1993025232A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6056978A (en) * 1992-06-16 2000-05-02 Stolle Milk Biologics, Inc. Use of hyperimmune milk to prevent suppression of T-lymphocyte production
AU2002367161A1 (en) * 2001-12-24 2003-07-15 Fonterra Co-Operative Group Limited Immunoglobulin composition
US9938558B2 (en) 2015-06-25 2018-04-10 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
WO2016210251A1 (en) 2015-06-25 2016-12-29 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
US10851399B2 (en) 2015-06-25 2020-12-01 Native Microbials, Inc. Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
NZ743958A (en) 2016-01-07 2023-07-28 Native Microbials Inc Methods for improving milk production by administration of microbial consortia
JP2020504620A (ja) 2016-12-28 2020-02-13 アスカス バイオサイエンシーズ， インコーポレイテッド 複雑な不均一コミュニティの完全微生物株の解析、その機能的関連性及び相互作用の決定、ならびにそれに基づく生物反応性の改変剤の同定及び合成、のための方法、装置、及びシステム
AU2017388535A1 (en) 2016-12-28 2019-07-25 Native Microbials, Inc. Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities with tracer analytics, determination of functional relationships and interactions thereof, and synthesis of microbial ensembles including dosed microbial ensembles and inoculative microbial ensembles
EP3614847A4 (en) 2017-04-28 2021-09-01 Native Microbials, Inc. PROCESSES PROMOTING ENERGY AND / OR CEREAL RICH DIETS BY MEANS OF A SYNTHETIC BIO-SET OF MICROBES

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0380032A1 (en) * 1983-10-27 1990-08-01 The Stolle Research And Development Corporation Use of milk for the manufacture of a hyperimmune milk composition for treating disorders of the pulmonary system in mammals

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3172807D1 (en) * 1981-04-28 1985-12-12 Stolle Res & Dev Method of obtaining an anti-inflammatory bovine milk
US4879110A (en) * 1983-10-27 1989-11-07 Stolle Research And Development Corporation Antihypertensive hyperimmune milk, production, composition, and use
JPS6099120A (ja) * 1983-11-04 1985-06-03 Asahi Glass Co Ltd ポリイソシアヌレ−ト系フオ−ムの製造方法
US4814359A (en) * 1987-12-30 1989-03-21 Union Carbide Corporation Process for producing flexible polyurethane foam using hexahydro-S-triazine catalysts
FI892006A (fi) * 1988-04-29 1989-10-30 Phil Gold Lactalbumin saosom tillaeggsaemne i mat.
JPH0699533B2 (ja) * 1988-11-24 1994-12-07 アキレス株式会社 ウレタン変性ポリイソシアヌレートフォームの製造方法
JPH04359036A (ja) * 1991-06-03 1992-12-11 Bridgestone Corp 硬質ポリウレタンフォ−ムの製造方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0380032A1 (en) * 1983-10-27 1990-08-01 The Stolle Research And Development Corporation Use of milk for the manufacture of a hyperimmune milk composition for treating disorders of the pulmonary system in mammals

Also Published As

Publication number Publication date
IL105912A (en) 1998-10-30
AU4525993A (en) 1994-01-04
EP0646014A1 (en) 1995-04-05
NZ299579A (en) 2000-09-29
JPH07507798A (ja) 1995-08-31
WO1993025232A1 (en) 1993-12-23
NZ505753A (en) 2004-11-26
NZ253866A (en) 1997-05-26
CA2136641A1 (en) 1993-12-23
EP0646014A4 (en) 1996-05-08
IL105912A0 (en) 1994-10-21

Similar Documents

Publication Publication Date Title
US6056978A (en) Use of hyperimmune milk to prevent suppression of T-lymphocyte production
Benyacoub et al. Supplementation of food with Enterococcus faecium (SF68) stimulates immune functions in young dogs
TWI539964B (zh) 用於廣效、未分類或混合型臨床應用之治療組合物及方法
JPH08231424A (ja) トリの抗体を用いた哺乳動物の受動免疫化
WO1997020577A1 (en) Improved therapeutic formulation and method
CA2267421A1 (en) Oral administration of chicken yolk antibodies to treat disease
US5106618A (en) Method of treating protozoal gastrointestinal disorders by administering hyperimmune milk product
AU680617B2 (en) The use of hyperimmune milk to increase longevity
US20050226861A1 (en) Immunogen adherence inhibitor and method of making and using same
WO1993025232A9 (en) The use of hyperimmune milk to increase longevity
Cebra et al. The role of mucosal microbiota in the development, maintenance, and pathologies of the mucosal immune system
US20020009429A1 (en) Pharmaceutical composition comprising a selected antigen and candida species antigen and methods
Xu et al. Bovine immune colostrum against 17 strains of diarrhea bacteria and in vitro and in vivo effects of its specific IgG
US7560109B2 (en) Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it
KR19980081625A (ko) 장관 출혈성 대장균에 의한 감염증의 예방제 및 치료제
US10478493B2 (en) Method of treating protozoal gastrointestinal disorders in immunocompromised patients
CA1339933C (en) Use of hyperimmune milk product to treat gastrointestinal disorders
CA2438698C (en) Immunogen adherence inhibitor and method of making and using same
Kweon et al. Partial IgA-Deficiency with Increased
NZ531390A (en) A method for production of a microbial adherence inhibitor for administration to host food animals to prevent the adherence of colony-forming organisms in the rumen or intestinal tract of the food animals
ZA200400673B (en) Immunogen adherence inhibitor and method of makingand using same.